PlaqueTec Ltd.

medical devices

About

PlaqueTec is pursuing a better understanding of the biological mechanisms of coronary artery disease (CAD) to advance the development of precision medicine. CAD, where atherosclerotic plaque build-up narrows or blocks the arteries that supply blood to the heart, is a leading cause of death globally. Current treatment approaches are one-size-fits-all and therefore ineffective for many patients. To address this, PlaqueTec has developed a proprietary technology and data analysis platform to endotype patients and uncover potential biomarkers of coronary vascular function and plaque progression. A more detailed understanding of patient endotypes will support drug development by identifying new targets in specific patient groups, reducing clinical trial sizes and costs, and increasing success rates, ultimately improving outcomes for patients.

Technologies

Outlook Google Cloud Hosting Mobile Friendly Varnish WordPress.org Wix Render Remote

Keywords

medical equipment manufacturing clinical trial optimization clinical research biomolecular signatures biomolecular gradients endotyping coronary artery disease lipidomics site-of-disease sampling liquid biopsy system biomarker gradients in cad biochemical profiling disease stratification services patient endotyping cad biomarkers clinical cohort studies target discovery medical research circulating calcium analysis collaborative research genomics biomarker gradients biomarker-based diagnostics local biomolecule detection healthcare technology disease heterogeneity molecular diagnostics biomarker analysis disease endotypes proteomics

Location

Babraham, England, United Kingdom, CB22 3AT

Related Companies

Companies in the same industry